
POV: Pharmacist
“Nulla feugiat ipsum arcu mi penatibus fringilla cursus ut mi. At eget condimentum pellentesque in amet.”
The Pharmacist's View >
Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.
The Pharmacist's View >
The Nurse's View >
June 30, 2025
Themes include: comparative effectiveness of LAAO vs. oral anticoagulants post-AF ablation, anticoagulant use in low-risk AF patients, superficial...
June 30, 2025
This systematic review strengthens previously published evidence that DOACs are likely a safe and effective treatment for confirmed or suspected HIT.
June 20, 2025
Order set implementation pre/post trial for trauma-associated VTE prevention
June 20, 2025
Review supporting multidisciplinary stewardship programs.
June 20, 2025
EHR Alerts for Prescribing DOACs.
June 20, 2025
Recommendations/discussion of educational strategies for patients to encourage comfort and adherence.
June 19, 2025
Systematic review of electronically monitored adherence.
June 19, 2025
The top-rated abstracts from the AC Forum 18th National Conference will be presented, showcasing key data and findings. Most research conducted on...
June 19, 2025
Retrospective cohort study of clinical decision support and DOAC ADEs.
Clinical FAQs provide practical guidance for healthcare professionals through offering evidence-based answers to common questions. These FAQs cover a wide range of topics to help healthcare professionals deliver high-quality patient care.
Should the dose of apixaban be reduced in the very elderly who do not meet two of the three dose reduction criteria (Age >80yo, SCr >1.5, <60kg WT)?
Read MoreHow much food needs to be eaten with a rivaroxaban dose and does meal timing (with breakfast, lunch, or dinner) matter?
Read MoreAre DOACs safe to use in those with low body weight (60 kg)? Should doses be reduced outside of package insert recommendations?
Read MoreJoining the AC Forum is quick, easy, and free—simply complete our online registration form, and you'll instantly access all membership benefits, including newsletters and webinar invitations. By becoming a member, you join a community of excellence dedicated to improving patient care and advancing the management of thromboembolic diseases. Take the next step in your professional journey and register now to start enjoying the benefits of membership today.
"The knowledge I gained from AC Forum has been invaluable in tackling complex patient cases. While I had a solid foundation, the resources and insights provided by AC Forum helped me expand my expertise significantly."
"The AC Forum Resource Center is a goldmine of information. The resources are incredibly helpful and directly applicable to my daily practice. I frequently turn to the AC Forum website for guidance and support."
"The AC Forum webinars offer invaluable insights into treatment options and the decision-making process behind them. Each patient is unique, and weighing the benefits and risks can be challenging. "